Glioblastoma: Overview of disease and treatment

Clinical Journal of Oncology Nursing

Volumn 20, Issue 5, 2016, Pages 1-8

  Davis, Mary Elizabeth ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Genomic profiling; Glioblastoma; Molecularly targeted therapy; Radiation; Surgery; Temozolomide; Tumor treating fields (TTFields)

Indexed keywords

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS;

EID: 84991721593     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/16.CJON.S1.2-8     Document Type: Article

References (58)

1. Alifieris, C., & Trafalis, D.T. (2015). Glioblastoma multiforme: Pathogenesis and treatment. Pharmacology and Therapeutics, 152, 63-82. doi:10.1016/j.pharmthera.2015.05.005
2. American Association of Neuroscience Nurses. (2014). Care of the adult patient with a brain tumor. Retrieved from http://www.abta.org/resources/health-care-provider/final-adult-clinical-practice.pdf
3. Barani, I.J., & Larson, D.A. (2015). Radiation therapy of glioblastoma. Cancer Treatment and Research, 163, 49-73. doi:10.1007/978-3-319-12048-5_4
4. Barone, D.G., Lawrie, T.A., & Hart, M.G. (2014). Image guided surgery for the resection of brain tumours. Cochrane Database of Systematic Reviews, 28, CD009685. doi:10.1002/14651858.CD009685.pub2
5. Bloch, O., Han, S.J., Cha, S., Sun, M.Z., Aghi, M.K., McDermott, M.W.,… Parsa, A.T. (2012). Impact of extent of resection for recurrent glioblastoma on overall survival. Journal of Neurosurgery, 117, 1032-1038. doi:10.3171/2012.9.JNS12504
6. Brandes, A.A., Bartolotti, M., & Francheschi, E. (2013). Second surgery for recurrent glioblastoma: Advantages and pitfalls. Expert Review of Anticancer Therapy, 13, 583-587. doi:10.1586/era.13.32
7. Brennan, C.W., Verhaak, R.G., McKenna, A., Campos, B., Noushmehr, H., Salama, S.R.,… Chin, L. (2013). The somatic genomic landscape of glioblastoma. Cell, 155, 462-477. doi:10.1016/j.cell.2013.09.034
8. Celldex Therapeutics, Inc. (2016). Data safety and monitoring board recommends Celldex’s phase 3 study of RINTEGA® (rindopepimut) in newly diagnosed glioblastoma be discontinued as it is unlikely to meet primary overall survival endpoint in patients with minimal residual disease [Press release]. Retrieved from http://ir.celldex.com/releasedetail.cfm?ReleaseID=959021
9. Chamberlain, M.C. (2011). Radiographic patterns of relapse in glioblastoma. Journal of Neuro-Oncology, 101, 319-323. doi:10.1007/s11060-010-0251-4
10. Chao, K.S.C., Perez, C.A., Brady, L.W., & Marinetti, T. (2011). Management of adult central nervous system tumors. In K.S.C. Chao, C.A. Perez, & L.W. Brady (Eds.), Radiation oncology: Management decisions (3rd ed., pp. 146-191). Philadelphia, PA: Lippincott Williams and Wilkins.
11. Chen, J., McKay, R.M., & Parada, L.F. (2012). Malignant glioma: Lesions from genomics, mouse models, and stem cells. Cell, 149, 36-47. doi:10.1016/j.cell.2012.03.009
12. Cohen, M.H., Shen, Y.L., Keegan, P., & Pazdur, R. (2009). FDA drug approval summary: Bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme. Oncologist, 14, 1131-1138. doi:10.1634/theoncologist.2009-0121
13. Davis, M.E. (2013). Tumor treating fields—An emerging cancer treatment modality. Clinical Journal of Oncology Nursing, 17, 441-443. doi:10.1188/13.CJON.441-443
14. Davis, M.E., & Stoiber, A.M. (2011). Glioblastoma multiforme: Enhancing survival and quality of life. Clinical Journal of Oncology Nursing, 15, 291-297. doi:10.1188/11.CJON.291-297
15. Ellor, S.V., Pagano-Young, T.A., & Avgeropoulos, N.G. (2014). Glioblastoma: Background, standard treatment paradigms, and supportive care considerations. Journal of Law, Medicine, and Ethics, 42, 171-182. doi:10.1111/jlme.12133
16. Franceschi, E., Bartolotti, M., Tosoni, A., Bartolini, S., Sturiale, C., Fioravanti, A.,… Brandes, A.A. (2015). The effect of reoperation on survival in patients with recurrent glioblastoma. Anticancer Research, 35, 1743-1748.
17. Franceschi, E., Tosoni, A., Bartolini, S., Mazzocchi, V., Fioravanti, A., & Brandes, A.A. (2009). Treatment options for recurrent glioblastoma: Pitfalls and future trends. Expert Review of Anticancer Therapy, 9, 613-619. doi:10.1586/era.09.23
18. Glantz, M.J., Cole, B.F., Forsyth, P.A., Recht, L.D., Wen, P.Y., Chamberlain, M.C.,… Cairncross, J.G. (2000). Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 54, 1886-1893. doi:10.1212/WNL.54.10.1886
19. Johnson, D.R., Fogh, S.E., Giannini, C., Kaufmann, T.J., Raghunathan, A., Theodosopoulos, P.V., & Clarke, J.L. (2015). Case-based review: Newly diagnosed glioblastoma. Neuro-Oncology Practice, 2, 106-121. doi:10.1093/nop/npv020
20. Johnson, D.R., & O’Neill, B.P. (2012). Glioblastoma survival in the United States before and during the temozolomide era. Journal of Neuro-Oncology, 107, 359-364. doi:10.1007/s11060-011-0749-4
21. Keles, G.E., Anderson B., & Berger, M.S. (1999). The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surgical Neurology, 52, 371-379. doi:10.1016/S00 90-3019(99)00103-2
22. Kuhnt, D., Becker, A., Ganslandt, O., Bauer, M., Buchfelder, M., & Nimsky, C. (2011). Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro-Oncology, 13, 1339-1348. doi:10.1093/neuonc/nor133
23. Lacroix, M., Abi-Said, D., Fourney, D.R., Gokaslan, Z.L, Shi, W., DeMonte, F.,… Sawaya R. (2001). A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. Journal Neurosurgery, 95, 190-198.
24. Lacy, J., Saadati, H., & Yu, J.B. (2012). Complications of brain tumors and their treatment. Hematology/Oncology Clinics of North America, 26, 779-796. doi:10.1016/j.hoc.2012.04.007
25. Lobera, A. (2015). Imaging in glioblastoma multiforme. Retrieved from http://emedicine.medscape.com/article/340870-overview
26. McGirt, M.J., Chaichana, K.L., Gathinji, M., Attenello, F.J., Than, K., Olivi, A.,… Quiñones-Hinojosa, A.R. (2009). Independent association of extent of resection with survival in patients with malignant brain astrocytoma. Journal of Neurosurgery, 110, 156-162. doi:10.3171/2008.4.17536
27. Moton, S., Elbanan, M., Zinn, P.O., & Colen, R.R. (2015). Imaging genomics of glioblastoma: Biology, biomarkers, and breakthroughs. Topics in Magnetic Resonance Imaging, 24, 155-163. doi:10.1097/RMR.0000000000000052
28. Mukherjee, D., & Quiñones-Hinojosa, A. (2011). Impact of extent of resection on outcomes in patients with high-grade gliomas. In M.A. Hayat (Ed.), Tumors of the central nervous system (Vol. 2, pp. 173-179). San Francisco, CA: Springer.
29. Narayana, A., Yamada, J., Berry, S., Shah, P., Hunt, M., Gutin, P.H., & Leibel, S.A. (2006). Intensity-modulated radiotherapy in high-grade gliomas: Clinical and dosimetric results. International Journal of Radiation Oncology Biology Physics, 64, 892-897. doi:10.1016/j.ijrobp.2005.05.067
30. National Comprehensive Cancer Network. (2015). Clinical Practice Guidelines in Oncology: Central nervous system cancers [v.1.2015]. Retrieved from https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf
31. Niyazi, M., Harter, P.N., Hattingen, E., Rottler, M., von Baumgarten, L., Proescholdt, M.,… Mittelbronn, M. (2016). Bevacizumab and radiotherapy for the treatment of glioblastoma: Brothers in arms or unholy alliance? Oncotarget, 7, 2313-2328. doi:10.18632/oncotarget.6320
32. Novocure. (2016). Optune®: Instructions for use. Retrieved from https://www.optune.com/Content/pdfs/Optune_IFU_8.5x11.pdf
33. Ostrom, Q.T., Bauchet, L., Davis, F.G., Deltour, I., Fischer, J.L., Langer, C.E.,… Barnholtz-Sloan, J.S. (2014). The epidemiology of glioma in adults: A “state of the science” review. Neuro-Oncology, 16, 896-913. doi:10.1093/neuonc/nou087
34. Ostrom, Q.T., Gittleman, H., Fulop, J., Liu, M., Blanda, R., Kromer, C.,… Barnholtz-Sloan, J.S. (2015). CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro-Oncology, 17(Suppl. 4), iv1-v62. doi:10.1093/neuonc/nov189
35. Ostrom, Q.T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J.,… Barnholtz-Sloan, J. (2014). CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro-Oncology, 16(Suppl. 4), ivl-63. doi:10.1093/neuonc/nou223
36. Parsons, D.W., Jones, S., Zhang, X., Lin, J.C., Leary, R.J., Angenendt, P.,… Kinzler, K.W. (2008). An integrated genomic analysis of human glioblastoma multiforme. Science, 321, 1807-1812. doi:10.1126/science.1164382
37. Perry, J., Zinman, L., Chambers, A., Spithoff, K., Lloyd, N., & Laperriere, N. (2006). The use of prophylactic anticonvulsants in patients with brain tumours—A systematic review. Current Oncology, 13, 222-229.
38. Phillips, H.S., Kharbanda, S., Chen, R., Forrest, W.F., Soriano, R.H., Wu, T.D.,… Aldape, K. (2006). Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell, 9, 157-173. doi:10.1016/j.ccr.2006.02.019
39. Pruitt, A.A. (2015). Medical management of patients with brain tumors. Continuum: Lifelong Learning in Neurology, 21, 314-331. doi:10.1212/01.con.0000464172.50638.21
40. Roder, C., Bisdas, S., Ebner, F.H., Honegger, J., Naegele, T., Ernemann, U., & Tatagiba, M. (2014). Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: High-field iMRI versus conventional and 5-ALAassisted surgery. European Journal of Surgical Oncology, 40, 297-304. doi:10.1016/j.ejso.2013.11.022
41. Salacz, M.E., Watson, K.R., & Schomas, D.A. (2011). Glioblastoma: Part I. Current state of affairs. Missouri Medicine, 108, 187-194.
42. Schiff, D., Lee, E.Q., Nayak, L., Norden, A.D., Reardon, D.A., & Wen, P. (2015). Medical management of brain tumors and the sequelae of treatment. Neuro-Oncology, 17, 488-504. doi:10.1093/neuonc/nou304
43. Shah, U., & Morrison, T. (2013). A review of the symptomatic management of malignant gliomas in adults. Journal of the National Comprehensive Cancer Network, 11, 424-429.
44. Shih, H.A., & Batchelor, T. (2016). Adjuvant radiation therapy for high-grade gliomas. Retrieved from http://www.uptodate.com/contents/adjuvant-radiation-therapy-for-high-grade-gliomas#H3
45. Stummer, W., Pichlmeier, U., Meinel, T., Wiestler, O.D., Zanella, F., & Reulen, H.J. (2006). Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial. Lancet Oncology, 7, 392-401. doi:10.1016/S1470-2045(06)70665-9
46. Stupp, R., Hegi, M.E., Mason, W.P., vanden Bent, M.J., Taphoorn, M.J., Janzer, R.C.,… Mirimanoff, R.O. (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTCNCIC trial. Lancet Oncology, 10, 459-466. doi:10.1016/S1470-2045(09)70025-7
47. Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J.,… Mirimanoff, R.O. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine, 352, 987-996. doi:10.1056/NEJMoa043330
48. Stupp, R., Taillibert, S., Kanner, A.A., Kesari, S., Steinberg, D.M., Toms, S.A.,… Ram, Z. (2015). Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: A randomized clinical trial. JAMA, 314, 2535-2543. doi:10.1001/jama.2015.16669
49. Stupp, R., Wong, E.T., Kanner, A.A., Steinberg, D., Engelhard, H., Heidecke, V.,… Gutin, P.H. (2012). NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomized phase III trial of a novel treatment modality. European Journal of Cancer, 48, 2192-2202. doi:10.1016/j.ecja.2012.04.011
50. Taal, W., Oosterkamp, H.M., Walenkamp, A.M., Dubbink, H.J., Beerepoot, L.V., Hanse, M.C.,… van den Bent, M.J. (2014). Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): A randomised controlled phase 2 trial. Lancet Oncology, 15, 943-953. doi:10.1016/S1470-2045(14)70314-6
51. Thakkar, J.P., Dolecek, T.A., Horbinski, C., Ostrom, Q.T., Lightner, D.D., Barnholtz-Sloan, J.S., & Villano, J.L. (2014). Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiology, Biomarkers and Prevention, 23, 1985-1996. doi:10.1158/1055-9965.EPI-14-0275
52. Verhaak, R.G., Hoadley, K.A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M.D.,… Hayes, D.N. (2010). Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17, 98-110. doi:10.1016/j.ccr.2009.12.020
53. Vitucci, M., Hayes, D.N., & Miller C.R. (2011). Gene expression profiling of gliomas: Merging genomic and histopathological classification for personalised therapy. British Journal of Cancer, 104, 545-553. doi:10.1038/sj.bjc.6606031
54. Walid, M.S. (2008). Prognostic factors for long-term survival after glioblastoma. Permanente Journal, 12(4), 45-48. doi:10.7812/TPP/08-027
55. Wang, H., Xu, T., Jiang, Y., Xu, H., Yan, Y., Fu, D., & Chen, J. (2015). The challenges and the promise of molecular targeted therapy in malignant gliomas. Neoplasia, 17, 239-255. doi:10.1016/j.neo.2015.02.002
56. Wilson, T.A., Karajannis, M.A., & Harter, D.H. (2014). Glioblastoma multiforme: State of the art and future therapeutics. Surgical Neurology International, 5, 64-62. doi:10.4103/2152-7806.132138
57. Young, R.M., Jamshidi, A., Davis, G., & Sherman, J.H. (2015). Current trends in the surgical management and treatment of adult glioblastoma. Annals of Translational Medicine, 3, 121.
58. Zhao, S., Wu, J., Wang, C., Liu, H., Dong, X., Shi, C.,… Li, H. (2013). Intraoperative fluorescence-guided resection of high-grade malignant gliomas using 5-aminolevulinic acid-induced porphyrins: A systematic review and meta-analysis of prospective studies. PLOS One, 8, e63682. doi:10.1371/journal.pone.0063682